Cargando…
COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A review of the potential mechanisms and proposed management
With over 600 million coronavirus (COVID-19) vaccine doses administered globally, adverse events are constantly monitored. Recently however, reports of thrombosis and thrombocytopenia following vaccination with the ChAdOx1 nCoV-19 vaccine have emerged. This paper aims to review the available literat...
Autor principal: | Alam, Walid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358704/ https://www.ncbi.nlm.nih.gov/pubmed/34120531 http://dx.doi.org/10.1177/00368504211025927 |
Ejemplares similares
-
Thrombocytopenia in COVID-19 and vaccine-induced thrombotic thrombocytopenia
por: Geronikolou, Styliani A., et al.
Publicado: (2022) -
COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A review
por: Sarkar, Malay, et al.
Publicado: (2022) -
COVID-19 vaccine-induced immune thrombotic thrombocytopenia: a review
por: Suhaimi, Siti Nur Atikah Aishah, et al.
Publicado: (2023) -
Vaccine-induced immune thrombotic thrombocytopenia
por: Klok, Frederikus A, et al.
Publicado: (2022) -
Vaccine-induced immune thrombotic thrombocytopenia
por: Kanack, Adam J., et al.
Publicado: (2022)